Mary Romano2-3, Vanessa Ferraro1-2*, Jose Luis Vallejo-Garcia1,2, Alessandro Randazzo1 and Paolo Vinciguerra1,2
1IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
2Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
3Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Neaples, Italy
*Corresponding Author: Vanessa Ferraro, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Received: July 21, 2022; Published: July 29, 2022
Purpose: To give clinical feedback to what the literature states about the different treatment of Central Serous Corioretinopathy (CSCR), outlining how, through different treatments customized on different characteristics of the patient it is possible to obtain excellent results of visual recovery.
Observations: While in acute forms a broad consensus has been reached on whether a wait-and-see attitude can be taken, in chronic forms the visual prognosis is very much influenced by the treatment to which it is subjected.
Conclusions: In the acute form (aCSCR), which has a relatively high rate of spontaneous resolution, an effective treatment should ideally prevent recurrences and subsequent disease progression. In the chronic form (cCSCR), the primary aim of treatment is currently to achieve and maintain the complete resolution of subretinal fluid.
Keywords: Subthreshold Micropulse Laser; Argon Laser; Eplerenone; Photodinamyc
Citation: Mary Romano., et al. “Different Therapeutic Approaches in Central Serous Corioretinopathy: A Case Series".Acta Scientific Ophthalmology 5.8 (2022): 101-105.
Copyright: © 2022 Vanessa Ferraro., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.